Chikungunya virus non-structural protein 2 (nsP2) inhibits RIG-I and TLR-mediated immune response
Abstract
Chikungunya virus (CHIKV) is a single-stranded positive-sense RNA virus that employs various strategies to evade the hosts immune response. The CHIKV non-structural protein 2 (nsP2) is one of the viral-encoded proteins essential for viral replication as well as modulation of the immune response. In this study, we demonstrate that CHIKV nsP2 suppresses both RIG-I-like receptors (RLR) and Toll-like receptors (TLR) signaling pathways. Domain mapping of the nsP2 identified the N-terminal region encompassing the N-terminal domain and the helicase domain (NH) is responsible for the inhibition. Furthermore, site-directed mutagenesis experiments showed that functional helicase is necessary for inhibiting interferon production, but the C-terminal V-Loop region, previously implicated in host transcriptional shutoff is not. Lastly, we demonstrate that nsP2 disrupts two key immune signaling pathways, RLR and TLRs, by interfering with common proteins, TBK1 and IRF3, involved in both signaling pathways. These findings enhance our understanding of CHIKV immune evasion strategies and offer potential targets for the development of antiviral therapeutics.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 6
- FWCI
- 2.21
- Field percentile
- top 11%
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Neuropilin-1 functions as a proviral and immunoregulatory host factor during Chikungunya virus infection
Kshyama Subhadarsini Tung, Chandan Mahish, … Subhasis Chattopadhyay·bioRxiv·Jul 27, 2026
- Chikungunya virus infection disrupts MHC-I antigen presentation via nonstructural protein 2
B. C. Ware, M. G. Parks, T. E. Morrison·bioRxiv·Nov 3, 2023
- The Chikungunya virus nsP3 macro domain inhibits activation of the NF-κB pathway
G. C. Roberts, N. J. Stonehouse, M. Harris·bioRxiv·Sep 5, 2019
- Drug Repurposing: A Potential Therapeutic Strategy for the Treatment of Chikugunya Virus
Siphokazi Zondi, Letitia Shunmugam, … Hezekiel Mathambo Kumalo·bioRxiv·Feb 19, 2026
- Identification of Inhibitors of Chikungunya virus nsP2 ATPase
Hernán A. Navarro, John E. Scott, … Peter J. Brown·bioRxiv·Dec 2, 2024
- DNA damage response signaling is crucial for effective Chikungunya virus replication
S. Chatterjee, S. Kumar, … S. Chattopadhyay·bioRxiv·Apr 12, 2022